We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ductal Lavage Helps to Assess Breast Cancer Risk

By HospiMedica staff writers
Posted on 29 Nov 2001
A study has found that a new technique called ductal lavage can help women at high risk of breast cancer choose strategies to reduce their risk, according to a report in the November 7, 2001, issue of the Journal of the National Cancer Institute. More...
The study was conducted by researchers at the University of Oklahoma (Norman, USA)

Since more than 95% of all breast cancers begin within ductal epithelial cells, those cells should show precancerous changes, or atypia, in a woman likely to develop breast cancer, say the researchers. In the new technique, an extremely thin tube is placed through a natural opening in the nipple into a milk duct. The duct is rinsed with salt water, and any cells that wash loose for microscopic exam are collected. An earlier method of obtaining cells for exam by suctioning nipple fluid (NAF) from the breast produced too few cells. The researchers used both techniques with 507 women at high risk of breast cancer.

Ductal lavage provided enough cells to examine in 78% of women, compared to only 27% of those who had the NAF technique, providing more than 100 times more cells. The researchers say the ductal lavage method was also more than three times as good at detecting abnormal cells. Women found with atypia can then seek ways to reduce their risk, such as taking the drug tamoxifen, or they may choose to have one or both breasts removed to prevent cancer from occurring.




Related Links:
Univ. of Oklahoma

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.